hexamethonium

This page covers all hexamethonium drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Neuronal acetylcholine receptor subunit alpha-6, Neuronal acetylcholine receptor subunit alpha-4, Neuronal acetylcholine receptor; alpha4/beta2.

Targets

Neuronal acetylcholine receptor subunit alpha-6, Neuronal acetylcholine receptor subunit alpha-4, Neuronal acetylcholine receptor; alpha4/beta2

Phase 2 pipeline (1)

• Hexanium · Neuroscience
  Hexamethonium works by blocking the action of acetylcholine at nicotinic receptors in the autonomic nervous system.

Patent intelligence

• hexamethonium patent landscape — aggregated cliff calendar, attackable patents, originator estates